Nephrocare Health
Listing performance
Scheduled dates
Tentative timetable — a past date is not confirmation the step completed
Grey market premium
Unofficial and indicative — not a forecast
3 observations recorded — too few to plot a trend.
Day-wise premium · 3 observations
| Date | GMP | % | Sauda | Est. listing | Gain / lot |
|---|---|---|---|---|---|
| 17 Dec 2025 | ₹40 | +8.70% | ₹1,000 | ₹500 | ₹1,280 |
| 16 Dec 2025 | ₹37 | +8.04% | ₹900 | ₹497 | ₹1,184 |
| 15 Dec 2025 | ₹37 | +8.04% | ₹900 | ₹497 | ₹1,184 |
Gain per lot assumes the premium holds to listing and that the application is allotted — allotment in an oversubscribed issue is a lottery, so it is indicative, not expected. Sauda is the rate paid for a submitted application itself.
Issue details
- Listing date
- 17 Dec 2025
- Face value
- ₹2 per share
- Issue price
- ₹460 per share
- Lot size
- 32 shares
- Total issue size
- ₹871 Cr
- Market cap at offer price
- ₹4,615 Cr
- Promoter holding
- 78.90% → 71.49% pre-issue → post-issue
- ISIN
- INE428V01029
- Registrar
- Kfin Technologies Ltd.
- Lead managers
- ICICI Securities Ltd.
- Registered office
- 5 th Floor, D Block, iLabs Centre, Plot 18, Software Units Layout, Survey No.64, Madhapur, Shaikpet, Telangana
Reservation and application size
How the issue is split between investor categories, and what each may bid
| Investor category | Shares | % of net | % of total |
|---|---|---|---|
| Anchor investor · within QIB | 56,57,919 | — | — |
| Market maker | 0 | — | — |
Application size
Minimum 32 shares per lot, in multiples, at ₹460
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (min) | 1 | 32 | ₹14,720 |
| Retail (max) | 13 | 416 | ₹1,91,360 |
| S-HNI (min) | 14 | 448 | ₹2,06,080 |
| S-HNI (max) | 67 | 2,144 | ₹9,86,240 |
| B-HNI (min) | 68 | 2,176 | ₹10,00,960 |
Category limits
| Category | Bid size | Cut-off |
|---|---|---|
| Retail (RII) | Up to ₹2 lakh | Yes |
| Small HNI (sNII) | ₹2 lakh – ₹10 lakh | No |
| Big HNI (bNII) | Above ₹10 lakh | No |
| Employee | Up to ₹5 lakh | Yes |
Bidding at cut-off means accepting the final issue price without naming one. Only retail and employee applicants may do so.
Anchor investors
Institutional allocation placed a day before the issue opens, carved out of the QIB portion and locked in after listing.
Valuation and performance
Valuation at offer price
₹460 per share
| Metric | Pre-issue | Post-issue |
|---|---|---|
| EPS (₹) | 7.24 | 2.84 |
| P/E (×) | 63.54 | 161.97 |
| Price to book (×) | 7.72 | — |
| Market cap | — | ₹4,615 Cr |
Key performance indicators
Latest reported period
- Return on net worth
- 13.19%
- ROCE
- 18.67%
- PAT margin
- 8.88%
- EBITDA margin
- 22.05%
- NAV per share
- ₹59.56
- Price to book
- 7.72
Single period as reported. Year-on-year movement is in the financials table below, where every period is published.